Edition:
United Kingdom

People: CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

9.97USD
3:52pm BST
Change (% chg)

$-0.15 (-1.48%)
Prev Close
$10.12
Open
$10.14
Day's High
$10.20
Day's Low
$9.77
Volume
29,477
Avg. Vol
172,871
52-wk High
$27.80
52-wk Low
$9.38

Fuchs, Charles 

Dr. Charles S. Fuchs, M.D., MPH serves as Director of the Company. Fuchs has served as a member of our board of directors since October 2017. Dr. Fuchs has been the Richard Sackler and Jonathan Sackler Professor of Medicine, Director of the Yale Cancer Center and Physician-in-Chief of the Smilow Cancer Hospital since January 2017. He was previously professor of medicine at Harvard Medical School and chief of the gastrointestinal oncology division and the Robert T. and Judith B. Hale Chair in Pancreatic Cancer at Dana-Farber Cancer Institute from July 2007 to December 2016. Dr. Fuchs received his medical degree from Harvard Medical School in 1986. He completed his medical residency at Brigham and Women’s Hospital, where he also served as chief medical resident, and completed his medical oncology fellowship at Dana-Farber Cancer Institute. In 1994, he received his M.P.H. from Harvard School of Public Health. We believe that Dr. Fuchs is qualified to serve on our board of directors due to his deep medical experience and service on the boards of directors of several cancer centers.

Basic Compensation

Total Annual Compensation, USD 6,658
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 322,885
Fiscal Year Total, USD 329,543

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Sean McCarthy

3,213,340

Debanjan Ray

1,563,120

Nick Galli

--

Leslie Robbins

--

W. Michael Kavanaugh

1,382,260

Rachel Humphrey

1,539,700
As Of  31 Dec 2017